The Immune System – News and Features

Learn more about the effects US pharmaceutical tariffs could have on European companies and their strategies for overcoming cost and supply chain challenges.

Inspired by cancer immunotherapy, scientists engineered immune cells equipped with specialized targeting devices called chimeric antigen receptors (CARs) that can distinguish and respond to tau tangles and various forms of toxic amyloid plaques.

Cultured human mini-organs have been used to map how aggressive Shigella bacteria infect the gut.

A study suggests that individuals with less diverse oral microbiomes are more likely to report symptoms of depression. The research highlights the potential link between oral health and mental well-being.

A new spatial transcriptomics analysis resource is helping scientists explore how genes behave differently in various parts of the body. This could help to zero in on exact biological processes that could be targeted to treat disease.

Researchers have discovered a new cell signaling pathway involved in ovulation, a potential target for future research on infertility, contraception and ovarian disease.

Researchers have conducted a preclinical study on the effects of the drug empagliflozin, alone or in combination with sacubitril/valsartan, in the early phase following a myocardial infarction.

A new method combines microscopy with single-cell RNA analysis to make the technique more accessible and scalable, giving researchers an advantage in the numbers game of single-cell analysis.

A study by the University of Queensland has revealed that the TAS2R38 gene, which controls bitterness sensitivity, is linked to various health conditions including bipolar disorder and chronic kidney disease.

Researchers have revealed the molecular details behind how vitamin K's membrane enzyme, vitamin K-dependent gamma carboxylase, directs blood clotting.